pDNA Production and Purification

BioProcess International

Home | Downstream | Upstream | Manufacturing | Archive

Webcast Information

pDNA Production and Purification

In recent years, there has been a growing demand for DNA-based therapeutics, commonly known as gene therapy, to combat genetically-based pathologies. Because plasmid DNA have significantly different biophysical characteristics than proteins, their production can have a drastic impact on downstream purification unit operations. Join Dr. Stephen Palmieri and Dr. Jesse McCool of Lonza Biologics and Dr. Fred Blattner of Scarab Genomics as they take a detailed look at the challenges faced by pDNA manufacturers and how Lonza’s pDNA Production Platform addresses those challenges.

View this webcast to learn more about the advantages of the Lonza pDNA purification process, such as:

Extremely high purity
Shorter process time
Low cost for resins

Targeted BPI Content

How Pore and Fibrous Interstice Structure Influence Filter Performance (Part 2)
BioProcess International, May 2010
Read more.

Using In-Line Disposable Pressure Sensors to Evaluate Depth Filter Performance
BioProcess International, February 2010
Read more.

How to Improve Your Implementation of Two-Dimensional Preparative HPLC
BioProcess International, October 2008
Read more.

The Emerging Generation of Chromatography Tools for Virus Purification
BioProcess International, October 2008
Read more.

Validation of Adventitious Virus Removal By Virus Filtration
BioProcess International, May 2008
Read more.

Hydrophobic-Interaction Membrane Chromatography for Large-Scale Purification of Biopharmaceuticals
BioProcess International, June 2009
Read more.